“EPIDEMIOLOGICAL AND CLINICAL CHARACTERISTICS OF CHILDREN WITH MEASLES RECEIVING INTRAVENOUS IMMUNOGLOBULIN TREATMENT”, YHCĐ, vol. 67, no. CĐ11-NCKH, Aug. 2026, doi: 10.52163/yhc.v67iCD11.6075.